# US 2010/0076416 A1 · Medical probes for the treatment of blood vessels

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0076416 A1
- Document ID: US20100076416A1
- Status: Published application
- Kind: A1
- Application number: 12/486,702
- Filed: 2009-06-17
- Published: 2010-03-25
- Earliest claimed: 2008-06-17
- Assignees: Tsunami MedTech, LLC
- Inventors: Michael HOEY; John H. SHADDUCK
- Web page: https://patentgrep.com/patent/US20100076416A1

## CPC

- A61F 7/12: Devices for heating or cooling internal body cavities
- A61B 18/18: by applying electromagnetic radiation, e.g. microwaves
- A61B 18/1815: {using microwaves}
- A61F 2/95: Instruments specially adapted for placement or removal of stents or stent-grafts
- A61B 18/24: with a catheter (A61B18/26, A61B18/28 take precedence)
- A61B 2017/00243: {cardiac}
- A61B 2017/22051: {with an inflatable part, e.g. balloon, for positioning, blocking, or immobilisation (A61B2017/22048, A61B2017/3486 take precedence)}
- A61B 2018/00011: {with fluids}
- A61B 2018/1861: {with an instrument inserted into a body lumen or cavity, e.g. a catheter}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Devices and methods for thermally-mediated treatment of blood vessels to elicit an immune response to cause rapid endothelial growth over at least portions of an implant or stent to prevent adverse events such as restenosis. Devices and methods for thermally-mediated treatment to inhibit contraction of vessels to

## Claims

### Claim 1

A method of reducing vasospasm in a blood vessel, the method comprising:
locating a target site within the blood vessel; and
applying an amount of thermal energy at the target site where the amount of thermal energy is sufficient to reduce an ability of a muscle in a blood vessel tissue to contract.

### Claim 2 (depends on 1)

The method of claim 1, where the thermal energy is sufficient to inhibit a function of actomyosin in the blood vessel tissue.

### Claim 3 (depends on 1)

The method of claim 1, wherein the thermal energy is sufficient to inhibit function of at least one of actin, myosin, myofilaments, titin filaments, nebulin filaments, and sarcomeric subunits in the blood vessel tissue.

### Claim 4 (depends on 1)

The method of claim 1, where applying thermal energy comprises applying an energy mode selected from the group consisting of Rf energy, light energy, ultrasound energy, resistive heating energy, inductive heating energy, mechanical energy and microwave energy.

### Claim 5 (depends on 1)

The method of claim 1, where applying thermal energy comprises irradiating the target site with light energy.

### Claim at position 6

6-8. (canceled)

### Claim 9 (depends on 1)

The method of claim 1, further comprising expanding a balloon in the target site and applying the thermal energy within the balloon.

### Claim 10 (depends on 1)

The method of claim 1, where applying the thermal energy comprises applying a flow media to the target site where the flow media comprises a heat of vaporization, where the flow media condenses at the target site to release the heat of vaporization to the blood vessel tissue causing an increase in temperature of the blood vessel tissue to reduce an ability of the muscle in the blood vessel tissue to contract.

### Claim 11 (depends on 10)

The method of claim 10, further comprising expanding a balloon at the target site and where applying the thermal energy comprises applying the flow media within the balloon.

### Claim 12 (depends on 10)

The method of claim 10, wherein, delivering the flow medial comprises delivering a vapor to the blood vessel to cause modification of contractile proteins in the blood vessel wall.

### Claim 13 (depends on 10)

The method of claim 10, where the flow media comprises a vapor content versus liquid droplet content of at least 50%.

### Claim 14 (depends on 10)

The method of claim 10, where the flow media comprises a heat of vaporization of at least 1200 kJ/kg.

### Claim 15 (depends on 10)

The method of claim 10, where applying the flow media comprises introducing an energy delivery device into the blood vessel, and delivering a vapor from the energy delivery device into the blood vessel.

### Claim 16

(canceled)

### Claim 17 (depends on 1)

The method of claim 1, wherein applying energy comprises applying energy uniformly about a wall of the blood vessel lumen.

### Claim 18 (depends on 1)

The method of claim 1, wherein applying the amount of thermal energy comprises applying the amount of thermal energy to inhibit the function of actomyosin in the blood vessel without ablating the blood vessel tissue.

### Claim 19 (depends on 1)

The method of claim 1, further comprising performing an angioplasty within the blood vessel.

### Claim 20 (depends on 1)

The method of claim 1, further comprising deploying a stent in the blood vessel.

### Claim 21 (depends on 1)

The method of claim 1, where applying the amount of thermal energy comprises
introducing a vapor media into the blood vessel and allowing the vapor media to change phase such that the change in phase delivers a selected level of energy to the blood vessel tissue to reduce an ability of a muscle in a blood vessel tissue to contract.

### Claim 22 (depends on 21)

The method of claim 21, where introducing the vapor media comprises introducing the vapor media into a balloon located within the blood vessel.

### Claim 23 (depends on 21)

The method of claim 21, further including expanding at least one occlusion balloon in the blood vessel to create an occluded region and where introducing the vapor media into the blood vessel comprises introducing the vapor into the occluded region.

### Claim at position 22

24-26. (canceled)

### Claim 27

A method comprising:
determining a library of data of operation parameters for applying a selected level of energy to reduce an ability of a muscle in a blood vessel tissue to contract using a model energy delivery system having energy application means in a working end configured for applying energy to a wall of a body vessel; and
providing the library of data for loading within a remote catheter system.

### Claim 28

(canceled)

### Claim 29

A method for treating a vascular site, comprising:
positioning a catheter working end in a treatment region in the vascular site;
applying a selected level of energy at the working end of the catheter, wherein the selected level of energy elicits an immune response to cause substantially rapid endothelial growth in the treatment region.

### Claim at position 26

30-87. (canceled)
